Recombinant Cavia porcellus CTLA-4/CD152 Protein (His Tag) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
CTLA-4 is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Cavia porcellus; expression system: P.Pichia; physical form: Supplied as a 0.2 μm filtered solution of PBS, pH7.4.; tag: Cavia porcellus ,CTLA-4 ,Recombinant Proteins; predicted molecular weight: 16-35 kDa.
Quality and formulation: purity: > 90 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.; concentration: Subject to label value..
Functional evidence: activity: Immobilized Mouse B7-1-Fc at 5 μg/ml (100 μl/well) can bind Cavia porcellus CTLA-4-His. The ED<sub>50</sub> of Recombinant Cavia porcellus CTLA-4-His is 4.29 ng/ml.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 16-35 kDa.
Database references: UniProt: H0VUB1 | Gene symbol: CTLA-4.
Research Use Only.
| Collaborator | Elabscience |
| Partner model | PKSQ050093_10ug |
| Target | CTLA-4 |
| Reactivity | Cavia porcellus |
| Concentration | Subject to label value. |
| Purity | >90% by SDS-PAGE |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Shelf life | 6 months |
| Availability | In stock - ships within 2 business days |
| Lead time | 2-3 business days |
| Category | Bioactivity | Binding | Cell-Based | In Vivo | ELISA Capture |
|---|---|---|---|---|---|
| Cavia porcellus |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
Quality management certification.
Environmental management certification.
Occupational health and safety management certification.
For research applications. Not for diagnostic use.
REACH compliant.
No customer reviews yet.
